RNA elements that are found in the genomes of numerous representatives within the same virus family provide new opportunities to expand the repertoire of targets for the development of antiviral therapy.
What cells does SARS-CoV-2 attack?
A collaborative team of German scientists identify which lung cells are susceptible to SARS-CoV-2 and why infection severity varies in different demographics.
Mouse study shows engineered virus could block coronavirus infections
Scientists engineer a virus known to be be harmless to humans to stimulate an immune response against the coronavirus family in mice.
The first reported case of COVID-19 community transmission in the U.S: A case study
A new case study monitors the evolution of testing guidelines in the face of a growing global pandemic.
Vaccine candidate against COVID-19 shows early promise
Potential vaccine against COVID-19 could begin human trials after FDA approval.
The four horsemen of the COVID-19 pandemic
The convergence of four broad but easily identifiable networked conditions, or “Four Horsemen”, are hurtling civilization towards potential self-destruction triggered by the current pandemic.
Virus-scanning tool could detect previous COVID-19 infections and aid in vaccine development
SARS-CoV-2 is being added to VirScan’s library, a virus scanning tool that can identify thousands of past and present pathogens in a single drop of blood.
Seeking connection through art in a pandemic
In facing a pandemic of this magnitude, coming together and seeking connection is more important than ever before.
Supercomputer simulates molecular model of SARS-CoV-2
Researchers at UT Austin hope their computer model of COVID-19 can help other scientists in developing new drugs against the virus.
Modeling study estimates the impact of physical distancing on reducing the spread of COVID-19
Researchers provide evidence for the effectiveness of isolation and quarantine measures in minimizing the spread of COVID-19.